A Safety, Tolerability, Efficacy and QoL Study of Human recAP in the Treatment of Patients With SA-AKI

NCT02182440 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

301

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Kidney Injury

Interventions

BIOLOGICAL: recAP
OTHER: Placebo

Sponsor

AM-Pharma

Collaborators

[object Object]